This study tests whether giving two drugs—nivolumab (immunotherapy) and cabozantinib (targeted therapy)—before removing the kidney can make all visible cancer disappear in people with advanced kidney cancer that has spread. About 38 adults with metastatic renal cell carcinoma wil…
Phase: PHASE2 • Sponsor: Mark Stein • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC